Status:
COMPLETED
Instant Message-guided Hypertension Management Intervention Among Stroke Survivors
Lead Sponsor:
The University of Hong Kong
Conditions:
Stroke
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot and feasibility study aims to develop an automated instant message-delivered intervention (i.e., EMI) for hypertension management in stroke survivors, and to investigate the feasibility and...
Detailed Description
Intervention group: Participants in intervention group will receive the EMI for 4 weeks. Based on the steps of mobile message development recommended by Abroms, et al., we will develop a message cont...
Eligibility Criteria
Inclusion
- Diagnosis of stroke (ICD-10 codes: I60-I69)
- Diagnosis of hypertension and antihypertension medication
- Aged ≥18
- Able to read and communicate in Chinese (Cantonese or Putonghua)
- Able to use text messaging function on mobile phones
- MoCA 5-minute Protocol (cognitive screen) ≥14 (Equivalence to MMSE ≥ 21)
Exclusion
- Currently receiving active stroke care in acute or post-acute inpatient settings
- Has diagnosis of psychiatric disease or is currently taking psychotropic drug
Key Trial Info
Start Date :
November 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06195969
Start Date
November 13 2023
End Date
January 12 2024
Last Update
July 11 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Kong PHAB Association
Hong Kong, Hong Kong
2
Queen Mary Hospital
Hong Kong, Hong Kong
3
Shatin Hospital
Hong Kong, Hong Kong
4
Southern District Elderly Community Centre
Hong Kong, Hong Kong